ora glp-1 up reviews GLP-1R–GIPR–PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice Structure's GLP-1 pill shows 'best-in-class'

pubmed.ncbi.nlm.nih.gov/37366315 Jastreboff AM, et al

It means youre gambling with a drug that hasnt been approved, from sellers who dont have to meet the same standards as real drug manufacturers

There's no strong research that shows that microdosing works well, and it isn't approved by the FDA, which means the agency hasn't reviewed it for safety

This slow ramp-up of the doses can potentially help reduce side effects moving forward

GIP Receptor Activity GIP is another incretin hormone that may contribute to glucose homeostasis and nutrient metabolism

Clinical studies show patients treated with GLP-1s experienced an average weight loss of 14.9-20.9% of their total body weight after 68-72 weeks